Patients with cutaneous squamous cell cancer of the head and neck who have disease recurrence after treatment have poor survival, according to a retrospective study.

“The findings underscore the importance of intensifying upfront treatment to prevent recurrence for high-risk patients, given the low rate of successful salvage,” said researcher Dr Bindu Manyam from the Cleveland Clinic in the US.